NIH Plans Closed Sessions for Brain and Eye Grant Reviews
Published Date: 5/7/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2025 to review and decide on important brain and eye disease research grant applications. These meetings keep sensitive info private to protect ideas and personal details. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Confidentiality protects applicants' ideas
The meetings are closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, patentable material, and personal information. This keeps applicants' sensitive research ideas and personal details private during grant review.
NIH grant reviews held June 2025
If you applied for NIH research grants in the listed study sections, your applications will be reviewed on these closed virtual meeting dates: June 5-6, 2025; June 6, 2025; and June 9-10, 2025. These reviews are the meetings that evaluate and decide on grant applications.
Virtual format — no public attendance or extra costs
All listed meetings are virtual and closed to the public, and they do not involve public attendance or extra costs. You will not be able to attend these meetings in person and there is no public travel required for the listed review dates.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in